Larry Biegelsen
Larry Biegelsen
believe boston credit maintain offer raise scientific share
We believe that Boston Scientific can raise its offer to $78 a share and still maintain an investment-grade credit rating.
continue count expect increasing pursue
Don't count BSX out yet. We expect BSX to continue to pursue GDT by potentially modifying or increasing its $72/share offer.